KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Humana (HUM) Divestments (2022)

Humana has reported Divestments over the past 4 years, most recently at -$7.0 million for Q4 2022.

Quarterly results put Divestments at -$7.0 million for Q4 2022, changed N/A from a year ago — trailing twelve months through Dec 2025 was -$7.0 million (changed 0.0% YoY), and the annual figure for FY2025 was $115.0 million, changed.
Divestments for Q4 2022 was -$7.0 million at Humana, down from $6.0 million in the prior quarter.
Over the last five years, Divestments for HUM hit a ceiling of -$7.0 million in Q4 2022 and a floor of -$7.0 million in Q4 2022.